NCT00422682 - A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid Tumors | Biotech Hunter

Enrollment

136

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

October 31, 2012

Conditions

Tumors

Interventions

DRUG

bsi-201 + topotecan

21 day cycle

DRUG

bsi-201 + temozolomide

28 day cycle

DRUG

bsi-201 + gemcitabine

28 day cycle

DRUG

bsi-201 + carboplatin/paclitaxel

21 day cycle

Trial Locations (6)

Research Site, New Haven

Research Site, Detroit

Research Site, New York

Research Site, Philadelphia

Research Site, Houston

Research Site, San Antonio